Findlay Park Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179M | Sell |
816,606
-29,600
| -3% | -$6.48M | 1.84% | 22 |
|
|
2025
Q1 | $189M | Buy |
846,206
+11,500
| +1% | +$2.57M | 1.95% | 21 |
|
|
2024
Q4 | $273M | Buy |
834,706
+7,000
| +0.8% | +$2.29M | 2.72% | 9 |
|
|
2024
Q3 | $248M | Buy |
827,706
+85,800
| +12% | +$25.8M | 2.34% | 11 |
|
|
2024
Q2 | $244M | Buy |
741,906
+144,800
| +24% | +$47.7M | 2.3% | 19 |
|
|
2024
Q1 | $236M | Buy |
597,106
+139,800
| +31% | +$55.3M | 2.17% | 18 |
|
|
2023
Q4 | $161M | Buy |
457,306
+180,415
| +65% | +$63.5M | 1.58% | 27 |
|
|
2023
Q3 | $104M | Sell |
276,891
-2,611
| -0.9% | -$980K | 1.12% | 40 |
|
|
2023
Q2 | $107M | Sell |
279,502
-17,538
| -6% | -$6.71M | 1.1% | 43 |
|
|
2023
Q1 | $103M | Buy |
297,040
+125,138
| +73% | +$43.4M | 1.09% | 42 |
|
|
2022
Q4 | $40.5M | Buy |
+171,902
| New | +$40.5M | 0.44% | 46 |
|